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Early increased renal procollagen al(IV) mRNA levels in streptozo-
tocin induced diabetes. Changes in renal procollagen mRNA levels were
measured shortly after the induction of streptozotocin induced diabetes
in the rat. "Medullary" procollagen al(IV) levels seven days after
diabetes induction was significantly higher in untreated diabetic rats
(DM, N = 12; 244 57% of the mean control value), than in diabetic
rats receiving small doses of insulin insufficient to achieve euglycemia
(NPH, N 10; 87 12%) and in diluent injected nondiabetic control
rats (C, N = 15; 100 12%; P < 0.01, DM vs. C and DM vs. NPH).
"Medullary" procollagen al(I) mRNA levels were numerically in-
creased in DM to a lesser degree (141 5%, ANOVA not significant)
compared to C (100 13%), and this small increment was further
normalized by insulin treatment (NPH, 120 11%). A trend for
increased -actin mRNA levels in DM did not reach significance (P >
0.05). Increases in "medullary" procollagen mRNA levels did not
correlate with kidney weight, glomerular tuft volume, creatinine clear-
ance, food intake, or body weight gain, and occurred when renal
morphology was normal by light microscopy. Statistically significant
but weak correlations were noted between the serum glucose levels and
"medullary" procollagen aI(IV) mRNA levels (r 0.43, P < 0.05). In
addition, weak correlations were noted between glycosuria and "med-
ullary" procollagen al(I) levels (r = 0.38, P < 0.05). In situ hybridiza-
tion studies localized the increased procollagen al(IV) mRNA levels
predominantly in the DM group primarily in the deep cortex and
medullary outer stripe of proximal tubules. Glomerular procollagen
al(IV), al(I), al(III) and /3-actin mRNA levels were not increased in
untreated diabetic rats 7 or 28 days after diabetes induction. Thus,
tubular procollagen al(IV) mRNA levels increased prior to any mea-
surable change in glomerular levels and were ameliorated by insulin
administration.
Diabetic kidney disease is characterized by changes in both
glomerular and tubular structure and function. Most studies
have focused on alterations in the glomerulus, including abnor-
malities in glomerular permeability and capillary pressure [1—61,
glomerular hyperplasia or hypertrophy [7—91, increases in base-
ment membrane width and fractional increases in mesangial
matrix volume [9—111. Although the effects of diabetes on the
renal tubulointerstitium have received relatively little attention,
tubular lesions were described in diabetes more than a century
ago [12, 13]. In fact, diabetic renal hypertrophy is largely a
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tubular process [14, 15], and abnormalities in tubular transport
and intracellular composition have been reported [16—19], as
have tubular basement membrane thickening and tubulointer-
stitial fibrosis [20—22].
Type IV collagen is a normal constituent of both tubular and
glomerular basement membranes and mesangial matrix. As
such, many experiments have focused on studying collagen
synthesis and degradation as a means of understanding the
pathogenesis of diabetic kidney disease [23—30], In the present
experiments, we tested the hypothesis that diabetic kidney
disease is at least in part due to an abnormality in extracellular
matrix gene expression. In these studies, in vitro and in situ
hybridization techniques were used to measure and localize
procollagen mRNA levels in the initial days after rats were
rendered diabetic by streptozotocin. These studies demonstrate
a prominent increase in procollagen zl(IV) mRNA levels local-
izing in proximal tubules of the deep cortex and outer stripe of
the renal medulla which could be completely abrogated by low
dose insulin insufficient to normalize renal size or serum glu-
cose levels. These tubular changes preceded any measurable
changes in glomerular procollagen mRNA levels.
Methods
Experimental animals
Seven-day in vitro hybridization studies. Male Sprague-Daw-
ley rats intended for glomerular and/or ruedullary mRNA mea-
surements were injected with streptozotocin 65 mg/kg i.p. in
sodium citrate buffer, pH4 or with buffer alone (N = 15) and
sacrificed after seven days. Induction of diabetes was ascer-
tained by measuring glycosuria by dipstick 24 hours after
streptozotocin administration. Ten of the diabetic rats received
2 units of NPH insulin s.c. daily (NPH) and twelve were left
untreated (DM). The following physiological measurements
were made prior to injection and again just before sacrifice
seven days later: body weight; serum and urine glucose (YSI
autoanalyzer II, Irvine, California. USA); hematocrit; systolic
arterial blood pressure by the tail cuff method in awake re-
strained animals [31]; and 24-hour urine protein by sulfosali-
cylic acid precipitation and turbidometric analysis [32]. The
food intake of each rat was measured daily beginning on the day
of buffer or streptozotocin injection.
Twenty-eight day in vitro hybridization studies. Since initial
in vitro and in situ hybridization studies revealed no significant
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changes in glomerular procollagen gene expression after only
seven days, a later time point during the course of the disease
process was deemed important to examine in untreated rats
with diabetes and in controls.
Therefore an additional 14 rats underwent diluent (N 7) or
streptozotocin (N = 7) injection and were sacrificed after 28
days. Physiological measurements identical to those performed
on rats sacrificed after seven days were made on these rats prior
to sacrifice. Glomeruli of these rats were utilized to assess
procollagen al(IV) and p-actin mRNA levels 28 days after
injection with streptozotocin or diluent.
In situ hybridization. Nine additional Sprague-Dawley rats
administered streptozotocin or diluent were sacrificed either
seven days or more than 120 days post-injection. Their kidneys
were harvested solely for in situ hybridization studies.
Rats were anesthesized with ketamine 87 mg/kg and xylazine
13 mg/kg i.m. prior to sacrifice and euthanized by exsan-
guination under general anesthesia.
Renal histology
Thin coronal renal sections were fixed in alcoholic Bouin's
solution, transferred after 24 hours into 70% ethanol, embedded
in paraffin, sectioned, and stained with periodic acid Schiff
reagent. Glomerular area was measured morphometrically in at
least 50 glomeruli from each rat using a Zeiss light microscope
and digitizer tablet. Glomerular tuft volume (GTV) was calcu-
lated using the following formula: GTV = 1.25 (glomerular
area)312 [32—34]. In vitro fixation, alcohol dehydration and
paraffin embedding may result in smaller glomerular area than is
measured in renal tissue fixed in situ [34].
In vitro hybridization studies—' 'Medulla"
Kidneys were removed from experimental and control rats
and the cortex separated from the medulla manually. The latter
tissue, consisting of a small segment of deep renal cortex
(approximately 1 mm) including deep juxtamedullary glomeruli,
and the renal medulla and papillae, are referred to as "medul-
la." "Medulla" samples were snap-frozen in liquid nitrogen.
Total RNA was extracted either by the guanidinium thiocyanate
(GT)/cesium chloride ultracentrifugation method [35] or by the
GT/phenol chloroform extraction method of Chomczynski and
Sacchi [36]. RNA was quantitated spectrophotometrically by
optical density readings at 260 nm. The quality of the RNA was
assessed by two methods. First, the optical density ratios of the
extracted RNAs were measured at 260 nm and 280 nm. Sec-
ondly, formaldehyde agarose gel electrophoreses were per-
formed, the samples stained with ethidium bromide, and trans-
illuminated by ultraviolet light to ensure the presence of intact
28S and 18S RNA bands.
For slot blot quantitation, five serial dilutions of samples of
total RNA from each rat were placed on nitrocellulose filters
(Hybond C extra, Amersham International, Amersham, UK or
Nitroplus 2000, Micron Separations, Inc., Westboro, Massa-
chusetts, USA), vacuum baked at 80°C for two hours, prehy-
bridized and subsequently hybridized overnight with specific
32p radiolabeled cDNA probes for procollagen al(IV), procol-
lagen al(I) or 3-actin. (Characteristics of cDNA probes are
detailed below). Procollagen al(I) mRNA was measured be-
cause it translates for a collagen peptide chain of major impor-
tance in the development of tubulointerstitial fibrosis. 13-actin
Table 1. Number of samples of "medullary" tissue from rats with
diabetes for seven days
C NPH DM
Procollagen al(IV) 14 9 9
Procollagen al(I) 9 9 6
/3-actin 14 9 9
mRNA was measured as a control. Hybridized filters were
washed to a stringency of 0.2 x SSC at 62°C (Hybond C) or 0.1
x SSC (with 0.1% SDS for f3-actin) at 37°C (Nitroplus 2000) and
developed with Kodak XAR film with two Quanta III intensi-
fying screens (Kodak, Rochester, New York, USA) at —70°C.
Developed autoradiograms were quantitated by laser densitom-
etry (Helena Laboratories, Beaumont, Texas, USA). Specific
procollagen and /3-actin mRNA levels were initially expressed
in optical density units per microgram of total RNA as calcu-
lated based on linear regressions for each experimental animal.
Values for each experimental rat were then expressed as the
percent of the mean value obtained in control rats. Due to the
use of two types of nitrocellulose paper, samples were directly
compared only among control and experimental samples ana-
lyzed using the identical nitrocellulose paper type (Hybond C
extra vs. Nitroplus 2000). In the final analysis, samples from
each rat were included if: 1) 260/280 nm RNA optical density
ratios were between 1.7 and 2.2; 2) formaldehyde agarose gel
electrophoresis disclosed intact 28S and 18S ribosomal RNA
bands; 3) a sufficient quantity of RNA was isolated to blot serial
dilutions for slot-blot quantitation; and 4) the correlation coef-
ficient for the linear regression of the slot-blot autoradiogram
was 0.85 utilizing a minimum of three dilutions. The number
of samples which met these criteria for each quantitative
mRNA measurement of "medullary" tissue derived from rats
with diabetes for seven days is in Table I.
In vitro hybridization studies—Glomeruli
Glomeruli collected from rats 7 and 28 days post-injection
were isolated from the renal cortex by differential sieving over
three sieves of mesh diameters 75, 106 and 125 microns [37].
The resultant glomerular samples were 85% pure. For glomer-
uli, the same criteria were utilized for RNA use as for "med-
ullary" tissue except that agarose gel electrophoreses were
performed only on representative samples due to the small
amount of RNA available from the glomerular pellet of each
experimental animal. The number of glomerular samples avail-
able for analysis from control and experimental rats 7 and 28
days after injection are in Table 2.
cDNA probes
The following eDNA probes were utilized: 1) mouse procol-
lagen al(IV) eDNA pPE123 [381; 2) human procollagen al(I)
cDNA Hf-677 [39]; 3) human procollagen al(III) cDNA Hf-934
[40]; and 4) rat /3-actin eDNA LK#280 [41]. Northern analysis
demonstrated unique binding of each of the probes with rat
mRNA. For pPE123 (Fig. lA) and Hf-677 [42], this resulted in
binding to mRNA of two molecular weights of 6.8 and 5.9 Kb
for the former and 5.8 and 4.8 Kb for the latter. For LK#280,
binding occurred to an mRNA of unique molecular weight (Fig.
1B), as was the case for Hf-934 (data not shown).
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Table 2. Number of glomerular samples from control and
experimental rats
C
7 28
days days
NPH
7
days
7
days
DM
28
days
Procollagen al(IV) 6 7 5 3 7
Procollagen al(I) 9 — 10 8 —
Procollagen a 1(111) 8 — 6 9 —
/3-actin 5 7 8 3 7
Fig. 1. Northern electrophoretic gel analysis. A. Binding of the procol-
lagen al(IV) cDNA probe pPE 123 to mRNA bands of 6.8 and 5.9 kb
(arrows). B. Binding of the /3-actin eDNA probe LK#280 to a 1.2 kb
mRNA band (arrows).
In situ hybridization
Quantitation of specific procollagen mRNA levels was ascer-
tained by slot-blot analysis. However, identification of the
specific cell types responsible for increased procollagen al(IV)
mRNA levels in the heterogeneous "medullary" tissue could
not be ascertained by this method. Thus, for localization
purposes only, nine additional animals were raised exclusively
for in situ hybridization studies and sacrificed either seven
days, or more than 120 days after diluent or streptozotocin
injection. In situ hybridization was performed with procollagen
al(IV) cDNA pPEl23, as well as with anti-sense and sense
cRNAs subcloned from pPE 123. Details of the subeloning
procedure are described below. Hybridization was performed
as described by Salido et a! [43] with minor modifications.
Renal tissue was perfusion fixed via an abdominal aortic
catheter with 4% paraformaldehyde in phosphate buffered
saline (PBS), pH 7.4, followed by immersion in this fluid for 30
minutes. Fixed tissue was rinsed in PBS, cryoprotected in 15%
sucrose in PBS for 30 minutes, embedded in OCT compound
(Miles Laboratories, Elkhart, Indiana, USA), snap frozen in
liquid nitrogen, sectioned at 6 to 10 microns, and mounted on
glass slides coated with 50 sg/ml polylysine (ICN Immunobio-
logicals Irvine, California, USA). Sections were predigested
with proteinase K, rinsed, and prehybridized for one to two
hours at 50CC in 20 d of a solution of 50% formamide, 0.3 M
NaCI, 20 m Tris (hydroxymethyl)-aminomethane (Tris) (pH
7.4), 5 m EDTA, 100 ms'i dithiothreitol, 100 g/m1 salmon
sperm DNA, and 10% dextran sulfate. As an additional negative
control, some sections were also pre-incubated with RNase 50
jsg/ml, 500 mM NaC1, 10 mM Tris pH 8.0, 1 m'vi EDTA and 10
mM thiosulfate for 30 minutes at 37°C. Hybridization proceeded
with the addition of the S-1abe1ed procollagen al(IV) cDNA,
control sense cRNA, or anti-sense cRNA probe to a solution
identical to the prehybridization mixture. Siliconized cover
slips were placed on the sections with the hybridization mixture
and the hybridization reaction was carried out at 50°C for 24
hours. Cover slips were removed with 4 x SSC and the tissue
was treated with 50 sg/ml RNase A for 30 minutes at 37°C and
then washed for one hour in 2 )< SSC at room temperature
followed by 30 minutes in 0.1 x SSC at 50°C. Sections were
dehydrated in a graded series of alcohol solutions, vacuum
dried, dipped in a 50% aqueous solution of photographic
emulsion NTB-2 (Eastman Kodak) at 45°C and exposed at 4°C
for periods from 10 to 13 days in bakelite boxes with desiccant.
Sections were developed with D19 developer (Eastman Kodak)
and fixed with Rapid Fix (Eastman Kodak). Selected sections
were counterstained with 0.5% methyl green. In addition, some
sections were stained with periodic acid Schiff stain prior to the
hybridization step. Sections were examined and photographed
with a Zeiss Axiophot photomicroscope using bright field, dark
field, and differential interference contrast condensers. The
pathologist was blinded to the experimental group origin of the
sections examined.
Preparations of cRNA probes
For generating procollagen al(IV) sense and antisense RNA
probes, the transcription vector pGEM-4Z (Promega Corpora-
tion, Madison, Wisconsin, USA) was used. Briefly, pPE123
cDNA type IV collagen-specific mouse clone was digested with
EcoR I and Hind III and subcloned into appropriate sites within
the multiple cloning site of pGEM-4Z. The resulting recombi-
nant plasmid, pGEM-PE123, was then linearized with an ap-
propriate restriction enzyme and in vitro transcription reactions
were performed according to the recommended conditions with
minor modifications. Transcription of 0.4 g template DNA was
carried out in a 30 pi reaction containing 10 mM DTF, 20 mol
each 01 ATP, GTP and UTP, 20 units of RNasin and 20 units of
SP6 or T7 RNA polymerase. Incubation was performed in the
presence of 35S-CTP (Amersham, specific activity 850 Ci/mmol)
at 37°C for T7 and at 40°C for SP6 RNA polymerases. The DNA
template was digested with RQ1 RNase-free DNase, the la-
belled cRNA was extracted with phenol/chloroform and chlo-
roform and precipitated with ethanol. The specific activity of
the probes obtained ranged from 2.0 to 4.0 x 108 cpm per
microgram of RNA synthesized. The specificity of the probe
was determined by using 32P-labeled sense and anti-sense
strands on Northern blots.
Statistics
Results are expressed as the mean standard error of the
mean (sEM). Comparisons among groups were made by
ANOVA using the Newman-Keuls multiple comparison test to
further identify individual differences. Comparisons between
groups were made using Student's t-test for normally distrib-
uted data and the Mann-Whitney rank sum test for non-
parametric data. Significance was assigned at the P < 0.05
level.
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Table 3. Physiological parameters in control (C), NPH insulin treated
(NPH) and untreated diabetic (DM) rats just prior to sacrifice 7 days
after diluent or streptozotocin injection
C NPH DM
Serum glucose mg/dl 138 8 284 27d,e 446 33
Urine glucose g/24 hr 0.02 0.01 1.00 0.20' 3.90 0.60c
Bloodpressure 114±10 112±5 114
mm Hg
Creatinine clearance! 1.2 0.2 1.7 0.3" 0.9 0.1
100 g body wt
Hematocrit % 45 1 46 1 49 I
Weight gain % of 27.8 1.9 15.8 7•4 35e
initial weight
Food intake g/24 hr/ 12.4 0.4 15.0 0.6 15.4 o.8
100 g body wt
Proteinuria mg124 hr 7.3 1.2 8.3 l.8' 49.9 10.23e
Kidney weight gI 1.7 0.1 2.1 0.lC 1.9 0.1
2 kidneys
Kidney weight/(body 9.0 0.3 10.8 0.3c 12.0 0.5c
weight x 10)
a P < 0.05 vs. C
b P < 0.05 vs. DM
P < 0.01 vs. C
d p < 0.01 vs. DM
a p < 0.001 vs. C
fp <0.001 vs. DM
Results
Experimental animals
Mean values from rats sacrificed seven days after injection
for serum and urine glucose, blood pressure, creatinine clear-
ance, hematocrit, body weight, food intake, proteinuria, kidney
weight, kidney weight to body weight ratio, and glomerular tuft
volumes are summarized in Table 3.
Serum and urine glucose levels were highest in untreated
diabetic rats (DM), intermediate in insulin treated diabetic rats
(NPH) and physiologic in control rats (C) seven days after
streptozotocin or buffer i.p. injection. Food intake/body weight
was higher in DM and NPH compared to C, but weight gain was
lower in DM and NPH compared with C. Body weights of all
three groups were similar on initiation (DM = 156 4 g; NPH
171 4 g; C = 155 4 g), but significantly lower in the DM
group at the termination of the experiment (DM = 167 7 g;
NPH 199 5 g; C = 197 7 g; P < 0.05 DM vs. NPH and
C). Creatinine clearance/body wt was highest in NPH, interme-
diate in C, and lowest in DM. Proteinuria was higher in DM
than NPH and C. No differences were noted in systolic arterial
blood pressure, serum creatinine, and hematocrit levels (P >
0.05). At sacrifice, absolute wet kidney weight was significantly
increased only in the NPH group (C = 1.8 0.1 g; NPH = 2.1
0.1 g; DM = 1.9 0.1 g; P <0.05 vs. C and DM), but kidney
weight corrected for BW was significantly greater in DM and
NPH compared to C.
Mean values of physiologic measurements for diabetic and
control rats sacrificed 28 days after injection are summarized in
Table 4. Mean serum and urine glucose levels were high in
untreated diabetic rats and physiologic in controls (P < 0.001).
Food intake factored for body weight was more discrepant
between the two groups at 28 days than was the case at 7 days,
with diabetic rats eating approximately 50% more than controls.
Despite the increased food intake, weight gain was 35 1% of
Table 4. Physiological parameters in control and untreated diabetic
rats just prior to sacrifice 28 days after diluent or streptozotocin
injection
C DM
Serum glucose mg!dl 127 5 448 49C
Urine glucose g/24 hr 0.01 0.00 4.89 l.28c
Blood pressure mm Hg 145 6 146 7
Creatinine clearance/100 g body wt 2.2 0.3 2.4 0.5
Hematocrit % 50 1 53 1
Weight gain % of initial weight 44 1 35 1"
Food intake g/24 hr!100 g body wt 29.1 0.6 43.3 2.2c
Proteinuria mg/24 hr 17.4 2.5 15.0 0.5
Kidney weight g12 kidneys 2.9 0.1 3.6 0,2b
Kidney weight/(body wt x 10-i) 8.6 0.3 12.7 0.6c
a < 0.05
b p < o.o
P < o.ooi
the initial body weight in the diabetic rats, and 44 1% of the
initial body weight in control rats (P < 0.01). Body weights
were identical in the two groups prior to injection (C and DM
185 3 g). At sacrifice C rats weighed 331 7 g and DM
weighed 285 10 g (P < 0.01). Creatinine clearance corrected
for body weight, proteinuria, systolic arterial blood pressure
and hematocrit were not significantly different between the two
groups (P> 0.05). At sacrifice, absolute kidney weight (C = 2.9
0.1 g, DM = 3.6 0.2 g, P < 0.01) and kidney weight
corrected for body weight (P < 0.001) were higher in the
diabetic than control rats, and these differences were greater
than those present seven days after disease induction.
Renal histology
Renal morphology in the control, insulin-treated and un-
treated groups was normal by light microscopy 7 and 28 days
after diluent or streptozotocin injection (Fig. 2). The vacuoliza-
tion of renal tubular epithelium ascribed to streptozotocin
induced nephrotoxicity [18] was not observed in either the
untreated or the insulin treated group. There was a trend toward
larger glomeruli in the DM and NPH groups compared to C both
at 7 days (3.5 0.3 and 3.8 0.2 vs. 3.2 0.2 x l0 p,
respectively), and at 28 days (C, 7.8 0.3 and DM, 8.6 0.3 x
l0 p3), but these differences did not reach statistical signifi-
cance.
In vitro hybridization of "medullary" RNA
In vitro mRNA-cDNA hybridization was performed on kid-
neys seven days post-injection to quantitate the procollagen
cd(IV), csl(I) and -actin mRNA levels in "medulla," com-
prised of the renal papillae, the inner and outer stripes of the
medulla, and approximately 1 mm of the deep cortex, including
a small number of juxtamedullary glomeruli. Mean procollagen
al(IV) mRNA levels in "medulla" were significantly higher in
DM (244 57%) than in C (100 12%) and NPH (86 11%) (P
< 0.01, DM vs. C and DM vs. NPH; Fig. 3). Marginal
increments in "meduilary" procollagen al(I) mRNA levels
were observed in the rats with untreated diabetes compared to
non-diabetic controls and insulin treated diabetic rats (C = 100
13%; DM = 141 5%; NPH 120 11%; ANOVA, not
significant; Fig. 3). Changes in /3-actin were also not signifi-
cantly different (C = 100 10%; DM = 164 39%; NPH 101
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Fig. 3. "Medullary" procollagen aI(IV), aI(!) and 13-actin mRNA
levels 7 days after diluent or streptozotocin injection. The procollagen
al(IV) mRNA level is significantly higher in DM () for both the DM
vs. C (•) and DM vs. NPH (El) comparisons (P < 0.01).
10%; ANOVA not significant). Although numerical increases
in mRNA levels were observed in all three mRNAs studied in
untreated diabetic rats, the increment in procollagen al(IV)
mRNA was of the greatest magnitude and was the only com-
parison to achieve statistical significance by ANOVA and by
the Student's f-test corrected for multiple comparisons. Thus,
while all mRNAs studied were numerically increased, the
magnitude and significance of the change was greatest for (and
therefore relatively specific for) procollagen s1(IV).
There were weak but statistically significant relationships
between "medullary" procollagen mRNA levels and serum
glucose levels, proteinuria, glycosuria, and kidney weight cor-
rected for body weight. Procollagen cxl(IV) mRNA levels were
significantly correlated to serum glucose levels (r 0.43, P <
0.05) and proteinuria (r = 0.43, P < 0.05). Procollagen ctl(I)
mRNA levels correlated with glycosuria (r 0.38, P < 0.05)
and with kidney weight corrected for body weight (r = 0.46, p
< 0.05). The relationship between procollagen aI(IV) mRNA
levels and glycosuria was of a similar magnitude (r = 0.37) but
fell just short of statistical significance (P >0.05). No significant
correlation was discerned between procollagen ctl(IV) mRNA
levels and kidney weight factored for body weight (r = 0.29, P
> 0.05).
In vitro hybridization of glomerular RNA
In vitro mRNA-cDNA slot-blot hybridization was performed
to quantitate the procollagen sl(IV), al(I), csl(III) and 13-actin
mRNA levels in control, untreated diabetic and insulin treated
diabetic rats seven days after diluent or streptozotocin injec-
tion. In addition, glomerular procollagen csl(IV) and /'3-actin
mRNA levels were measured in control and untreated diabetic
rats 28 days after injection. No significant increments were
noted in procollagen al(IV), ctl(I), al(IlI) or f3-actin mRNA
Fig. 2. Representative sections of deep renal cortex from rats 7 days
after streptozotocin or buffer injections. A. Control rat. There are no
abnormalities of the tubules, interstitium or glomerulus. B. Diabetic rat
with NPH insulin treatment. The tubulointerstitium and glomerulus are
normal. C. Untreated diabetic rat. There is no vacuolization, necrosis
or atrophy of tubules. The interstitium and glomerulus have no alter-
ations. Periodic acid Schiff x250.
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Table 5. Glomerular procollagen and 13-actin niRNA levels in control, NPH insulin-treated diabetic, and untreated diabetic rats expressed as a
% of the mean control value
C NPH
7 days
DM
7 days 28 days 7 days 28 days
Procollagen al(IV)
Procollagen aI(I)
Procollagen al(III)
/3-actin
100 22
100 24
100 16
100 18
100 6
—
100 19
98 12
115 17
—
85 8
69 16
125 15
82 9
91 1
135
140
33
—
—
11
levels in the insulin treated or untreated diabetic rats compared
to control animals seven days after injection (Table 5). For this
reason, glomerular procollagen al(IV) and /3-actin mRNA
levels were measured in control and untreated diabetic rats 28
days post-injection. Again, no significant differences between
the two groups were observed in procollagen al(IV) or /3-actin
mRNA levels (Table 5).
In situ hybridization
These autoradiographic studies were performed to localize
the cellular origin of the increase in "medullary" procollagen
al(IV) mRNA levels measured in the untreated diabetic rat
kidneys by in vitro hybridization. In situ hybridization with
radiolabeled procollagen al(IV) cDNA and antisense cRNA
probes revealed similar findings.
Utilizing the cDNA probe, by light field microscopy, silver
grains identifying the procollagen al(IV) mRNA were rarely
seen in tubules or glomeruli of control rats either seven days or
longer than 120 days after diluent injection, consistent with a
relatively low abundance baseline expression for this message
(Fig. 4A). Renal tissue from insulin treated diabetic rats had few
silver grains in proximal tubular cells or glomeruti, not appre-
ciably increased in number from those in control kidneys (Fig.
4B). In contrast, rats made diabetic for seven days had clearly
identifiable increased numbers of silver grains localized pre-
dominantly but not exclusively in proximal tubules of the deep
cortex and outer medullary stripe (Fig. 4C). Fewer grains were
present in proximal tubules of the outer cortex, as well as a
scattering of grains in distal tubules and collecting ducts. The
majority of tubules disclosing the increased number of silver
grains were identified as proximal by their location, morphology
and brush border staining with periodic acid Schiff. Silver
grains on renal sections from rats with untreated diabetes for
more than four months were distributed similarly to the rats
with diabetes for seven days, but grains were present in greater
number and tended to be more confluent (Fig. 4E). No increase
in silver staining was present in glomeruli from animals diabetic
for seven days, and basal expression of this mRNA as identified
by this method was barely detectable.
By darkfield microscopy, the distribution of the staining was
identical to that observed by light microscopy but was more
apparent overall. In both control and NPH treated rats, rare
white granules corresponding to sites of procollagen al(IV)
mRNA could be discerned in the renal tubules, predominating,
but not exclusively in, the proximal tubules of the deep cortex
and outer medullary stripe. Autofluorescence of tubular base-
ment membranes was also apparent. In contrast, in untreated
diabetic rats prominent and widespread proximal tubular stain-
ing was present in the deep cortex and outer medullary stripe,
with scattered, less prominent granularity in the superficial
cortex and inner medulla in untreated diabetic rats seven days
after injection (Fig. 4D). This pattern was preserved in rats with
untreated diabetes for more than four months, but, as in the
light microscopic examination, heavier granularity was present
in rats with more prolonged diabetes (Fig. 4F).
With the cRNA probe, the distribution of the increased
procollagen al(IV) mRNA in the diabetic rat kidney was
virtually identical to that observed with the cDNA probe, these
being predominant increments in proximal tubular cytoplasm,
and, to a much lesser extent, increased expression in distal
tubules. While the histologic distribution of the lesions were
identical with the cDNA and cRNA probes, the cRNA tended
to bind quantitatively more than the cDNA (Fig. 5A). Thus, the
in situ studies were utilized only for the purpose of mRNA
localization, and not for quantification.
No silver grains were present on sections hybridized with
sense cRNA probes (Fig. SB), or on those renal sections
pre-treated with RNase prior to in situ hybridization.
Discussion
Thick glomerular and tubular basement membranes, ex-
panded mesangial matrix, tubulointerstitial fibrosis and renal
hypertrophy and hyperplasia are characteristics of the diabetic
kidney. Since Type IV collagen is a constituent element of
basement membranes and mesangial matrix, alterations in its
synthesis and/or degradation may contribute to the develop-
ment of diabetic renal disease. These experiments were per-
formed in order to determine whether early diabetes is associ-
ated with an alteration in procollagen mRNA abundance. In this
study, "medullary" and glomerular procollagen and f3-actin
mRNA levels were measured in rats 7 and/or 28 days after
diluent or streptozotocin injection. In vitro hybridization exper-
iments demonstrated a significant increase in procollagen
al(IV) mRNA levels in the "medullary" tissue of these diabetic
rats, while procollagen al(I) and /3-actin mRNA levels were
numerically but not statistically significantly elevated. Further
studies utilizing in situ hybridization techniques localized the
increase in procollagen al(IV) mRNA predominantly to the
proximal tubular cells of the deep cortex and outer stripe of the
renal medulla. Glomerular procollagen ul(IV), al(I), al(III)
and f3-actin levels were not increased at the time points studied.
Thus these experiments demonstrate an increase in proximal
tubular procollagen al(IV) mRNA levels in the kidneys of rats
with untreated diabetes mellitus. This increment preceded any
change in mRNA levels in the glomerulus. The specificity of
this observation lies not so much in the uniqueness of the
mRNA that is expressed, but rather in the restricted localiza-
tion within the kidney of that enhanced expression.
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Fig. 4. cDNA in Situ hybridization for procollagen aI(IV) mRNA in proximal tubules of the deep cortex and outer medullary stripe. A. Buffer
injected control after 7 days. Few silver grains are evident. B. NPH insulin treated diabetes after 7 days. As in controls, few silver grains are presentin proximal tubules. C,D. Untreated diabetes after 7 days. Moderate numbers of silver grains (arrowheads) are present within proximal tubular
epithelium. E,F. Untreated diabetes after >4 months. Many silver grains (arrowheads) are within the proximal tubule cells. A,B,C,E-methyl green
x625. D,F Darkfield )<275.
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Fig. S. In situ hybridization of diabetic rat deep cortex using cRNA
probe for procollagen al(IV) mRNA. A. Antisense probe. There is
heavy labelling of proximal tubules with silver grains (arrowheads) with
fewer grains in other tubules. B. Sense probe. There are virtually no
silver grains present. Methyl green x200.
The findings reported herein complement some and conflict
with other work in experimental diabetes. In a model of
non-insulin dependent diabetes in the KKAy mouse, Ledbetter
et al demonstrated an increase in renal cortical procollagen
al(IV) mRNA levels beginning at two months of age, but
becoming statistically significant at four months of age [44].
Studies to localize the cellular origin of this mRNA were not
performed. Killen et al [45], in a preliminary study, reported a
statistically significant increase in whole kidney procollagen
aI(IV) and Bi laminin mRNA levels in insulin treated rats made
diabetic by streptozotocin (P < 0.05) and a similar, but statis-
tically insignificant trend for increased procollagen al(IV)
mRNA in untreated diabetic rats (P > 0.05). Our results differ
from those of Killen et al in that the procollagen al(IV) mRNA
levels in our untreated diabetic rats were significantly (P < 0.01)
higher than in our controls, and were normalized by insulin
treatment. This discrepancy may be largely technical. The
experiments by Killen et al were performed on RNA isolated
from whole kidney, while ours were done on tissue comprised
almost exclusively of medulla and renal papillae. Since the
increase in message localizes to the deep cortex and the
superficial medulla, it is possible that the failure to detect
increases in procollagen al(IV) mRNA levels in untreated
diabetic rats is due to the presence of superficial renal cortex in
the whole kidney study which "dilutes" the message, thereby
diminishing the power to observe differences. While our study
and the work of Ledbetter et al [44] and Killen et al [45] show
an increase in procollagen al(IV) mRNA levels in diabetic
kidney under some experimental conditions, it should be noted
that not all studies have been able to confirm a relationship
between diabetes and increases in renal procollagen al(IV)
mRNA. Poulsom et al [46] showed diminished whole kidney
procollagen al(IV) mRNA levels in rats rendered diabetic by
streptozotocin compared to controls. While it is difficult to
speculate about the reasons for these discrepant findings, it is
possible that these disparities may be ascribed to differences in
rat strain, age, nutritional status, severity and/or duration of
diabetes, method of RNA quantitation, cDNA probes utilized
and, once again, segments of the kidney studied.
Taken together, however, these data tend to support the
premise that the abnormal metabolic milieu of diabetes is
capable of inducing increases in vivo in procollagen al(IV)
mRNA levels in the diabetic kidney. The precise mechanism for
this event in the proximal tubule remains speculative. The effect
of diabetes may be a direct one, mediated perhaps by an
increase in glucose transport during states of hyperglycemia
and marked glycosuria. In vitro, Ziyadeh has demonstrated that
proximal tubules cultured in high glucose medium expressed
increased levels of procollagen al(I) and al(IV) mRNA and
secrete more Type I and Type IV collagen than tubules cultured
in low glucose medium [47]. However, the observation in
tubules in vitro lacks cell-type specificity. Similar increases in
collagen production or mRNA levels have been noted in vitro
when mesangial cells [48] umbilical vein endothelial cells [49],
and neural connective tissue cells [50] are cultured in high
glucose medium. Thus, the relative specificity of the localiza-
lion in vivo suggests a mechanism other than simply high
glucose concentrations, which might be predicted on the basis
of these in vitro experiments to affect cell types besides tubules.
One may speculate that the increased transport activity of the
deeper proximal tubules during states of marked hyperglycemia
are in some way linked to the induction of the collagen message.
However, in this study, only a weak correlation was observed
between the serum glucose levels and the procollagen csl(IV)
mRNA levels, and no significant association was noted with the
degree of glycosuria.
The relationship between diabetes and increased proximal
tubular procollagen al(IV) mRNA levels might also be a
function of the development of renal hyperplasia or hypertro-
phy. However, in this study, while wet kidney weight corrected
for body weights were similar in the insulin treated and un-
treated rats, elevations in procollagen al(IV) mRNA occurred
only in the latter group. This suggests that hypertrophy by itself
is not a sufficient condition to induce measurable increments in
procollagen al(IV) mRNA levels. It is doubtful that increased
renal function or hyperfiltration are responsible for the incre-
ments in the procollagen al(IV) mRNA levels noted in these
kidneys. This is borne out by the fact that the highest procol-
lagen mRNA levels were seen in the group with the lowest
creatinine clearance corrected for body weight (untreated dia-
betic group) and the lowest levels were seen in the group with
the highest creatinine clearance corrected for body weight
(insulin treated diabetic group). Finally, the increase in procol-
lagen al(IV) mRNA levels in the proximal tubules of diabetic
rats may be due to streptozotocin nephrotoxicity. Increased
proteinuria without concomitant albuminuria in our untreated
diabetic rats compared to control rats at seven days but not 28
days suggests that there may have been tubular dysfunction in
the diabetic rats sacrificed one week after injection. We believe
that this tubular dysfunction was not due to streptozotocin
nephrotoxicity, and that streptozotocin toxicity is not the cause
of the increase in procollagen al(IV) mRNA levels for the
following reasons. The typical findings of vacuolated proximal
tubular cells characteristic of rats with streptozotocin nephro-
toxicity [51, 52] were not observed in our diabetic rats. In
addition, rats receiving the same dose of streptozotocin, but
who were treated with daily low dose insulin did not have
abnormal proteinuria. Moreover, similar increases in presump-
tive tubular proteinuria occur in diabetic mice [53] where no
streptozotocin is involved in lesion induction. Furthermore, by
in situ hybridization, the proximal tubular expression of procol-
lagen al(IV) mRNA persisted in the rats injected with strepto-
zotocin greater than four months previously, suggesting an
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effect of prolonged duration. The persistence and possible
enhancement of the mRNA signal in the tubules for a prolonged
period of time after a single injection of streptozotocin argues
against drug-induced nephrotoxicity as the inciting cause for the
increase in mRNA observed. Thus, there is little likelihood that
streptozotocin itself is directly related to increased message
levels in this experiment.
While the mechanism of increased tubular procollagen al(IV)
mRNA levels remains uncertain in acute diabetes, it is interest-
ing that low-dose insulin therapy insufficient to achieve eugly-
cemia or to inhibit hypertrophy suppressed this rise. Experi-
rnents concerning the effect of insulin on collagen synthesis and
accretion have been inconclusive. Insulin has been reported to
increase glomerular collagen synthesis in vitro by some [54] and
to decrease it by others [55, 56]. Low dose insulin treatment has
previously been shown to inhibit the non-specific increase in
total glomerular RNA observed in diabetic rats [571. However,
in our study, the increase in "medullary" mRNA levels in
untreated compared to insulin treated rats was 2.8-fold for
procollagen al(IV) mRNA, 1.2 fold for procollagen al(I)
mRNA and 1.6-fold for /3-actin mRNA. The greatest decrement
in mRNA levels associated with insulin treatment was therefore
observed for procollagen al(IV). The disparity in the magnitude
of the insulin effect on the mRNA levels for the different peptide
chains studied suggests more specificity than merely a general-
ized suppression by insulin of all mRNAs expressed.
The molecular mechanisms underlying the increased procol-
lagen al(IV) mRNA levels in diabetic rat tubules cannot be
discerned from this study. Enhanced gene transcription, as well
as stabilization of the mRNA are both possible explanations for
the greater abundance of procollagen al(IV) mRNA observed
in these experiments. The increase in proximal tubular procol-
lagen al(IV) mRNA levels was noted prior to the full expres-
sion of renal hypertrophy and before glomerulosclerosis and
tubulointerstitial fibrosis developed in these diabetic animals.
These findings support the premise that diabetic renal disease
may be associated with an acquired dysregulation in the process
of transcription and/or translation of basement membrane col-
lagen.
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